Zeravion · AI intelligence layer for urine analysis
Turning continuous urinalysis into predictive intelligence.
Zeravion transforms continuous urinary biomarker data into predictive health intelligence — learning individual patterns, detecting meaningful change and enabling earlier action.
The body is continuous. Healthcare still takes snapshots.
Urine carries a continuous stream of information about what is happening inside the body. Yet conventional urinalysis captures only isolated moments.
Zeravion changes the model from testing to continuous interpretation.
The intelligence chain
From repeated measurements to longitudinal individual profiles
By turning repeated biomarker measurements into longitudinal individual profiles, Zeravion creates the data foundation for detecting change — and predicting what comes next.
- 01
Sense
Urinary biomarker data
- 02
Learn
Individual baseline
- 03
Detect
Meaningful deviations
- 04
Predict
Disease risk & biological change
- 05
Act
Earlier intervention
How it works
From a single reading to a continuous signal trail.
- 01
Sensing hardware
A low-cost optical reader captures urinary biomarkers at the point of life — no lab, no shipment, no waiting.
- 02
In-home integration
Embedded into the surfaces people already use — starting with the toilet — so measurement happens passively, every time.
- 03
Real-time longitudinal data
Each reading joins a connected trail, building the baseline that lets change become visible.
Hardware-agnostic by design
The sensor can change. The intelligence gets smarter.
As new sensing technologies emerge, urinary data can be captured across different devices, environments and care settings. Each new data source strengthens the longitudinal intelligence layer, expanding what Zeravion can learn, detect and ultimately predict.
Capture surfaces
- Toilet
- Catheter
- Diaper
- Animal farming
- Smart surfaces
- Future sensors
Intelligence models
Zeravion AI→UTIKidneyMetabolicOncology
The first application
Zeravion Horizon
Zeravion Horizon brings continuous urinary intelligence into clinical research, using a toilet-integrated 10-parameter platform to generate high-frequency longitudinal biomarker data for pharmaceutical trials.
Why it matters
Health changes gradually. Detection should too.
Meaningful change rarely announces itself in a single test. Seen against an individual baseline, small shifts become early signals — for the people living with a condition, and for the teams studying it.
